Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Poulsen

Showing results (81-90 of 184) with videos related to

Pageof 19
Sort By:
Theranostics|November 23, 2019
CD4<sup>+</sup> and CD8a<sup>+</sup> PET imaging predicts response to novel PD-1 checkpoint inhibitor: studies of Sym021 in syngeneic mouse cancer modelsLotte K Kristensen, Camilla Fröhlich, Camilla Christensen, et al.
Free Radical Biology & Medicine|January 21, 2021
Superoxide dismutase 3 is expressed in bone tissue and required for normal bone homeostasis and mineralizationCecilie L Matthiesen, Lili Hu, Astrid S Torslev, et al.
Journal of the Peripheral Nervous System : JPNS|November 23, 2006
Artemin has potent neurotrophic actions on injured C-fibresDavid L H Bennett, Timothy J Boucher, Gregory J Michael, et al.
The Journal of Biological Chemistry|September 24, 2017
How glycosaminoglycans promote fibrillation of salmon calcitoninKirsten Gade Malmos, Morten Bjerring, Christian Moestrup Jessen, et al.
The Journal of Biological Chemistry|June 10, 2016
How Glycosaminoglycans Promote Fibrillation of Salmon CalcitoninKirsten Gade Malmos, Morten Bjerring, Christian Moestrup Jessen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2015
Pan-HER, an Antibody Mixture Simultaneously Targeting EGFR, HER2, and HER3, Effectively Overcomes Tumor Heterogeneity and PlasticityHelle J Jacobsen, Thomas T Poulsen, Anna Dahlman, et al.
Molecular Cancer Therapeutics|April 17, 2026
ADCE-T02 - a Next Generation Antibody Drug Conjugate Targeting Tissue Factor Demonstrates Superior Preclinical Efficacy and TolerabilityThomas T Poulsen, Olga Ilina, Jonathan H Wardman, et al.
Free Radical Biology & Medicine|July 6, 2010
The concentration of extracellular superoxide dismutase in plasma is maintained by LRP-mediated endocytosisSteen V Petersen, Ida B Thøgersen, Zuzana Valnickova, et al.
Molecular Cancer Therapeutics|July 16, 2025
The recycling collagen receptor uPARAP is a unique mediator of stromal drug delivery to carcinoma cellsKirstine S Nørregaard, Ida M E Larsen, Henrik J Jürgensen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 23, 1998
Neurturin exerts potent actions on survival and function of midbrain dopaminergic neuronsB A Horger, M C Nishimura, M P Armanini, et al.
Pageof 19

Showing results (81-90 of 184) with videos related to

Sort By:
Pageof 19
Theranostics|November 23, 2019
CD4<sup>+</sup> and CD8a<sup>+</sup> PET imaging predicts response to novel PD-1 checkpoint inhibitor: studies of Sym021 in syngeneic mouse cancer modelsLotte K Kristensen, Camilla Fröhlich, Camilla Christensen, et al.
Free Radical Biology & Medicine|January 21, 2021
Superoxide dismutase 3 is expressed in bone tissue and required for normal bone homeostasis and mineralizationCecilie L Matthiesen, Lili Hu, Astrid S Torslev, et al.
Journal of the Peripheral Nervous System : JPNS|November 23, 2006
Artemin has potent neurotrophic actions on injured C-fibresDavid L H Bennett, Timothy J Boucher, Gregory J Michael, et al.
The Journal of Biological Chemistry|September 24, 2017
How glycosaminoglycans promote fibrillation of salmon calcitoninKirsten Gade Malmos, Morten Bjerring, Christian Moestrup Jessen, et al.
The Journal of Biological Chemistry|June 10, 2016
How Glycosaminoglycans Promote Fibrillation of Salmon CalcitoninKirsten Gade Malmos, Morten Bjerring, Christian Moestrup Jessen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2015
Pan-HER, an Antibody Mixture Simultaneously Targeting EGFR, HER2, and HER3, Effectively Overcomes Tumor Heterogeneity and PlasticityHelle J Jacobsen, Thomas T Poulsen, Anna Dahlman, et al.
Molecular Cancer Therapeutics|April 17, 2026
ADCE-T02 - a Next Generation Antibody Drug Conjugate Targeting Tissue Factor Demonstrates Superior Preclinical Efficacy and TolerabilityThomas T Poulsen, Olga Ilina, Jonathan H Wardman, et al.
Free Radical Biology & Medicine|July 6, 2010
The concentration of extracellular superoxide dismutase in plasma is maintained by LRP-mediated endocytosisSteen V Petersen, Ida B Thøgersen, Zuzana Valnickova, et al.
Molecular Cancer Therapeutics|July 16, 2025
The recycling collagen receptor uPARAP is a unique mediator of stromal drug delivery to carcinoma cellsKirstine S Nørregaard, Ida M E Larsen, Henrik J Jürgensen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 23, 1998
Neurturin exerts potent actions on survival and function of midbrain dopaminergic neuronsB A Horger, M C Nishimura, M P Armanini, et al.
Pageof 19